Sound Therapy & Binaural Beats: What Studies Really Show

Context: What is sound therapy and binaural beats?

Sound therapy is an umbrella term for acoustic interventions that—depending on the study—pursue very different goals (e.g., stress, pain, tinnitus). Binaural beats are a specific method within that category: two slightly different tone frequencies are played to the ears so the brain processes the resulting beat.

Section 1: Context: What is sound therapy and binaural beats?

Binaural beats occur when slightly different frequencies are played to each ear (e.g., left ear X Hz, right ear Y Hz). The difference frequency produces what is called a difference tone, which listeners perceive and/or the brain processes as a kind of “beat.” In practice, audio files/generators are typically used to drive the frequencies separately for each ear (usually via headphones).

By contrast, sound therapy includes anything that intervenes through the auditory system: from music therapy to specifically structured sound patterns to combined protocols where binaural beats are coupled with other elements. This is where a core interpretation problem arises: studies often differ substantially in (a) the stimulation type (binaural beats alone vs. combined with music), (a) the duration of the intervention, (c) the participants (e.g., healthy individuals vs. people with chronic tinnitus), and (d) the outcome variables (e.g., cognition, anxiety, pain, tinnitus symptoms, or neurophysiological markers). As a result, a strict 1:1 comparison between studies is often only partially possible.

For your decision-making, this matters: if you expect effects, you shouldn’t only ask “does it work?” but “for which endpoint under which conditions?” Evidence is not equally robust everywhere. In the set of studies you listed, this is particularly clear for cognition/anxiety/pain (meta-analysis) compared with tinnitus (mostly RCTs with varying designs that are frequently combination-dependent). At the same time, sound interventions are—under most sensible setups—an add-on rather than a substitute strategy for diagnostic evaluation and treatment when symptoms persist.

Section 2: Lifestyle first: Why sleep, stress, and movement are the foundation

Sound therapy can show effects in studies, but the largest levers for “lower stress” or “higher cognition” are usually sleep, stress regulation, and movement—and these factors can often be influenced more reliably and more strongly. If you want to use sound, it should therefore be approached as a complement built on a solid base.

Before seriously considering sound interventions as an “option,” it’s important to check the basics of stress biology and brain function. Especially for goals like stress reduction, anxiety, or general mental performance, lifestyle parameters are often the tuning knobs with the best signal-to-noise ratio: sleep duration and sleep quality drive recovery, emotion regulation, and learning processes. Stress management (e.g., breath regulation, decoupling from triggers, structured breaks) affects physiological parameters that also shape perception and symptom appraisal.

This becomes especially relevant if you consider sound therapy as an add-on for tinnitus-like complaints: many people report that stress and strain intensify symptom perception. If you address noise management, hearing protection, and medical evaluation at this stage, it becomes easier to detect any real effects from sound interventions. Otherwise, you may be mixing effects from multiple sources—so you can’t tell whether changes came from better sleep, lower daily stress, or the audio setup.

Also: even if studies find positive effects on certain outcomes, that is not automatically a free pass. You need clear outcome measurement (e.g., stress scales or tinnitus assessment) and a setup that minimizes expectation effects. For many people, it’s pragmatic to stabilize the lifestyle baseline first and then add only one additional variable (sound) as a test. This also matches the logic of your study list: some RCTs address stress directly as a target (Kelton et al., 2021, PMID 32619206), while others in tinnitus often test more complex combined interventions (Bakhtarikia et al., 2024, PMID 38723376; Ibarra-Zarate et al., 2022, PMID 34563804). That suggests you shouldn’t treat sound as a “blind” universal tool.

If symptoms persist or neurological signs develop, a medical evaluation is appropriate—especially for hearing issues. Sound interventions may be supplements, but they are not a replacement for diagnostic work-up.

Section 3: Evidence hierarchy: Which endpoints are covered by meta-analyses and RCTs?

The evidence base is endpoint-dependent: for cognition, anxiety, and pain, your list includes a meta-analysis that aggregates the evidence into an overall signal. For tinnitus, RCTs investigate binaural sound interventions, sometimes as a standalone strategy and often—frequently—as a combination with other acoustic elements. RCT results may therefore appear less consistent and are often strongly shaped by the study design (including combinations).

In your study list, the highest evidence tier for the endpoints cognition, anxiety, and pain is covered directly via a meta-analysis: (Garcia-Argibay et al., 2019, PMID 30073406). A meta-analysis combines results from many studies into a single overall impression. Methodologically, this is stronger than a single RCT, because differences in sample characteristics and individual outlier studies may be less dominant. Still, a meta-analysis is only as good as the underlying primary studies (methodological quality, effect homogeneity, and measurement instruments).

For tinnitus, the picture is more nuanced. The RCTs/clinical trials in your list examine binaural auditory interventions either as a standalone strategy or—often—as a combination with other acoustic components. For example, (Bakhtarikia et al., 2024, PMID 38723376) explicitly tests music therapy combined with binaural beats in chronic tinnitus. This makes it harder to conclude that “only binaural beats work,” because the effect could theoretically come from the music component (or be driven mainly by it). Similarly, (Ibarra-Zarate et al., 2022, PMID 34563804) evaluates binaural auditory materials within a psychometric and neurophysiological framework. In addition, there are RCT data that address the comparative perspective: (Schad et al., 2018, PMID 29022411) compares acoustic therapies for tinnitus suppression (a preliminary trial design). Here, “comparison” doesn’t automatically mean superiority, but it does indicate what interventions were actually tested and how outcomes were measured.

One more point: not every study reporting neurophysiological or EEG-adjacent effects automatically translates into clinical improvement. (Wahbeh et al., 2007, PMID 17388762) is a pilot study in your list that investigates neuropsychological, physiological, and electroencephalographic effects—more as mechanism/signal measurement than as long-term symptom outcomes. And (Schroeer et al., 2021, PMID 33639814) focuses on electrophysiological aspects of speech-induced binaural beats, showing that binaural interaction effects can be measured (but that does not automatically mean tinnitus reliably improves clinically).

In summary: if you want to prioritize, orient yourself toward endpoints with stronger aggregated evidence (cognition/anxiety/pain via meta-analysis) and treat tinnitus as an area where you should expect more combination-dependent and sometimes mixed results.

Section 4: Study overview: What was investigated—and what came out?

Overall, meta-analyses and RCTs show a pattern: general psychological/experience-based endpoints are more often reported as positive, while tinnitus outcomes vary depending on design—often combined with additional acoustic components or strongly dependent on outcome measurement and protocol details.

Here is a compact study overview along your list:

Important for interpretation: a “positive study” doesn’t automatically mean you can derive a universal protocol today. Especially for tinnitus, note that multiple RCTs in your list include combination-dependent or endpoint-specific designs (Bakhtarikia et al., 2024, PMID 38723376; Ibarra-Zarate et al., 2022, PMID 34563804; Schad et al., 2018, PMID 29022411). At the same time, mechanism studies (Wahbeh et al., 2007, PMID 17388762) or electrophysiological investigations (Schroeer et al., 2021, PMID 33639814) do not automatically provide the same level of clinical evidence.

If you want to make a decision for yourself, a realistic framework helps: ask first about the endpoint (stress, anxiety, pain, cognition vs. tinnitus) and then about the study type (meta-analysis vs. RCT vs. pilot/mechanism). That is how the evidence landscape in your source list becomes most “readable.”

Section 5: Dosage & approach: How to translate study concepts into practice

In your study list, the plan text lacks concrete stimulation parameters (e.g., exact carrier frequencies, difference tones, loudness in dB, minutes per session). Therefore, the most important translation rule is: strictly follow the details of the specific study that match the endpoint design you are targeting—and plan your own testing as a structured A/B or pre-post evaluation with clearly defined metrics.

The second key point: generalizability is not only about “dose” in the sense of duration. It also depends on whether the intervention was tested alone or combined. A clear example from your list: (Bakhtarikia et al., 2024, PMID 38723376) investigates music therapy combined with binaural beats in chronic tinnitus. If you derive a pure binaural-beat strategy from that, you may be missing a component that contributed to the observed effects in the study design. Likewise, in (Schad et al., 2018, PMID 29022411), the perspective is comparing acoustic therapies; “binaural” is not necessarily the same thing as the single best or only component.

For stress as a target, (Kelton et al., 2021, PMID 32619206) in your list provides an RCT approach as a stress-buffering technique. Practically, that means you need a stress-measurement setup that you can replicate in your daily life. For example (without skipping the study itself): use a validated stress instrument or at least consistent scales (before and after the relevant time window). The advantage of an A/B or pre-post design is that it helps separate expectation effects and day-to-day variability—even if you don’t randomize as strictly as in an RCT.

With tinnitus, the experimental arrangement is especially delicate. In the RCTs in your list, the setting varies (e.g., clinical populations, psychometric vs. neurophysiological endpoints, combinations). That’s why you shouldn’t claim a “standard dose” that applies across all protocols (Bakhtarikia et al., 2024, PMID 38723376; Ibarra-Zarate et al., 2022, PMID 34563804; Schad et al., 2018, PMID 29022411). Practically, if you want to test, document precisely: start date, session length, frequency/sound profiles (as detailed as possible), volume, headphone type, and whether noise reduction/hearing protection occurs in parallel.

Another pragmatic element: mechanistic and electrophysiological studies can tell you whether your setup is even “physiologically compatible.” (Wahbeh et al., 2007, PMID 17388762) provides evidence in your list for neuropsychological/physiological/EEG-adjacent effects. But even if you get a “signal,” it doesn’t automatically mean your symptom scale (e.g., tinnitus scores) will decrease—you still need endpoint measurement.

Section 6: Safety, limits, and “what isn’t proven”

The safety picture in your study list is not robust enough to justify a blanket long-term reassurance. Therefore: proceed conservatively, take ear and neurological warning signs seriously, and consider sound therapy primarily as an adjunct—not a replacement for medical evaluation.

In the study list you provided, the topic of “safety” is not covered as a comprehensive long-term safety program. That’s crucial: if an intervention does not show broad long-term safety data within its own evidence base (or if that evidence is not present in your list), you should not assume safety. In this sense, your list does not provide a clear safety statement for all applications and endpoints—especially not for more intensive or long-term self-experiments.

What you can do instead is plan with low risk: if you have relevant ear conditions, significant hearing problems, or new neurological symptoms, it’s sensible to seek medical evaluation before you intervene more intensively through sound. This caution is particularly relevant because binaural beats act via the auditory pathway, and you won’t know how sensitive your system might be when problems already exist.

A further boundary comes from endpoint-dependent evidence. For cognition/anxiety/pain, (Garcia-Argibay et al., 2019, PMID 30073406) aggregates an overall signal. For tinnitus, however, the RCT results in your list are less clear, and designs often include combinations (Bakhtarikia et al., 2024, PMID 38723376; Ibarra-Zarate et al., 2022, PMID 34563804). “Not clearly conclusive” is not a contradiction to the mechanism idea—it shows that clinical outcomes are influenced by many factors.

Mechanism studies also aren’t the same as clinical safety/effectiveness: (Wahbeh et al., 2007, PMID 17388762) investigates neuropsychological/physiological/EEG-adjacent effects. That can suggest physiological responsiveness, but it does not replace robust symptom reduction over long timeframes. And (Schroeer et al., 2021, PMID 33639814) addresses electrophysiological aspects of binaural interaction—clinical tinnitus endpoints are therefore not automatically covered.

Finally, (Mirmohamadi et al., 2024, PMID 39228447) provides a review that offers context. But even a review cannot “scale up” the quality of the primary evidence. Therefore, the key takeaway remains: data are endpoint-dependent, and the evidence in your list is not robust enough to support “safety as a general blanket guarantee.”

If you still want to test, keep it as a controlled, short-cycle experiment with clear stop rules (e.g., new worsening of symptoms, persistent headaches, notable hearing changes). And keep treating lifestyle levers as the base—this reduces the chance you’ll miss the real problem if the sound effect is unclear.

Bottom Line: What to take away

• Endpoint decides: The strongest aggregated evidence in your list concerns cognition, anxiety, and pain (Garcia-Argibay et al., 2019, PMID 30073406). For tinnitus, RCT evidence is more mixed, and often combination-dependent (Bakhtarikia et al., 2024, PMID 38723376; Ibarra-Zarate et al., 2022, PMID 34563804; Schad et al., 2018, PMID 29022411).
• Mechanism ≠ clinical effect: EEG/physiological effects (Wahbeh et al., 2007, PMID 17388762; Schroeer et al., 2021, PMID 33639814) are important, but they do not automatically translate into symptom reduction.
• Lifestyle first: In practice, sound therapy is most sensible as an adjunct to sleep, stress regulation, and hearing health, because these levers typically have stronger and more reliable effects.
• Translation requires study details: Without the specific stimulation parameters from each study, you shouldn’t adopt a “standard dose”; test in a structured way (Kelton et al., 2021, PMID 32619206 provides an example framework as a stress-buffering RCT).
• Safety is not broadly proven: Your list lacks robust long-term safety data. If you have ear/neurology signals, get assessed beforehand and act conservatively (Mirmohamadi et al., 2024, PMID 39228447 for context).